To elucidate whether MD6a acts as a PARP-1 inhibitor to contribute to protecting mitochondrial function in PD, we measured the oxygen consumption rate (OCR), ATP levels, movement ability, mitochondrial ROS production and mitochondrial membrane potential. Here, PARP1 is linked to Parkinson disease.